IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Medical Letter on Drugs and Therapeutics

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

0.67

h-Index

2022-2023

 20

Rank

2022-2023

 18655

SJR

2022-2023

 0.211

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Medical Letter on Drugs and Therapeutics
Abbreviation Med. Lett. Drugs Ther.
Publication Type Journal
Subject Area, Categories, Scope Pharmacology (medical) (Q3); Medicine (miscellaneous) (Q4); Pharmacology (Q4)
h-index 20
Overall Rank/Ranking 18655
SCImago Journal Rank (SJR) 0.211
Impact Score 0.67
Publisher Medical Letter Inc.
Country United States
ISSN 0025732X, 15232859
Best Quartile Q3
Coverage History 1965-2022




About Medical Letter on Drugs and Therapeutics


Medical Letter on Drugs and Therapeutics is a journal covering the technologies/fields/categories related to Pharmacology (medical) (Q3); Medicine (miscellaneous) (Q4); Pharmacology (Q4). It is published by Medical Letter Inc.. The overall rank of Medical Letter on Drugs and Therapeutics is 18655. According to SCImago Journal Rank (SJR), this journal is ranked 0.211. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 20. The best quartile for this journal is Q3.

The ISSN of Medical Letter on Drugs and Therapeutics journal is 0025732X, 15232859. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Medical Letter on Drugs and Therapeutics is cited by a total of 171 articles during the last 3 years (Preceding 2022).


Medical Letter on Drugs and Therapeutics Impact IF 2022-2023


The Impact IF 2022 of Medical Letter on Drugs and Therapeutics is 0.67, which is computed in 2023 as per its definition. Medical Letter on Drugs and Therapeutics IF is increased by a factor of 0 and approximate percentage change is 0% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Medical Letter on Drugs and Therapeutics Impact IF 2023 Prediction


Impact IF 2022 of Medical Letter on Drugs and Therapeutics is 0.67. If the same upward trend persists, Impact IF may rise in 2023 as well.


Impact IF Trend


Year wise Impact IF of Medical Letter on Drugs and Therapeutics. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 0.67
2021 0.67
2020 0.55
2019 0.53
2018 0.54
2017 0.43
2016 0.53
2015 0.71
2014 0.40

Medical Letter on Drugs and Therapeutics h-index


  Table Setting

Medical Letter on Drugs and Therapeutics has an h-index of 20. It means 20 articles of this journal have more than 20 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Medical Letter on Drugs and Therapeutics ISSN


The ISSN of Medical Letter on Drugs and Therapeutics is 0025732X, 15232859. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Medical Letter on Drugs and Therapeutics Rank and SCImago Journal Rank (SJR)


The overall rank of Medical Letter on Drugs and Therapeutics is 18655. According to SCImago Journal Rank (SJR), this journal is ranked 0.211. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Medical Letter on Drugs and Therapeutics by Year


Year SJR
2023/2024 Coming Soon
2022 0.211
2021 0.254
2020 0.246
2019 0.357
2018 0.577
2017 0.328
2016 0.429
2015 0.357
2014 0.156

Ranking of Medical Letter on Drugs and Therapeutics by Year


Year Ranking
2023/2024 Coming Soon
2022 18655
2021 16310
2020 16894
2019 12752
2018 8362
2017 12559
2016 10475
2015 11860
2014 20152

Medical Letter on Drugs and Therapeutics Publisher


Table Setting

Medical Letter on Drugs and Therapeutics is published by Medical Letter Inc.. It's publishing house is located in United States. Coverage history of this journal is as following: 1965-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Medical Letter on Drugs and Therapeutics is Med. Lett. Drugs Ther.. This abbreviation ('Med. Lett. Drugs Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Medical Letter on Drugs and Therapeutics


If your research field is/are related to Pharmacology (medical) (Q3); Medicine (miscellaneous) (Q4); Pharmacology (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Medical Letter on Drugs and Therapeutics?

Medical Letter on Drugs and Therapeutics latest impact IF is 0.67. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 0.71 (2015) and 0.40 (2014), respectively, in the last 9 years. Moreover, its average IS is 0.56 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Medical Letter on Drugs and Therapeutics?

The Medical Letter on Drugs and Therapeutics has an SJR (SCImago Journal Rank) of 0.211, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.577 in 2018 and the lowest being 0.156 in 2014. Furthermore, the average SJR of the Medical Letter on Drugs and Therapeutics over the previous 9-year period stands at 0.56.


What's the latest h-index of the Medical Letter on Drugs and Therapeutics?

The latest h-index of the Medical Letter on Drugs and Therapeutics is 20.


Who's the publisher of the Medical Letter on Drugs and Therapeutics?

The Medical Letter on Drugs and Therapeutics is published by the Medical Letter Inc., with its country of publication being the United States.


What's the current ranking of the Medical Letter on Drugs and Therapeutics?

The Medical Letter on Drugs and Therapeutics is currently ranked 18655 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 8362 in 2018 and its lowest position of 20152 in 2014.


What's the abbreviation or short name for the Medical Letter on Drugs and Therapeutics?

The standard ISO4 abbreviation for the Medical Letter on Drugs and Therapeutics is Med. Lett. Drugs Ther..


Is the "Medical Letter on Drugs and Therapeutics" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Medical Letter on Drugs and Therapeutics is classified as a journal that the Medical Letter Inc. publishes.


What's the scope or major areas of the Medical Letter on Drugs and Therapeutics?

The Medical Letter on Drugs and Therapeutics encompasses the following areas:

  • Pharmacology (medical)
  • Medicine (miscellaneous)
  • Pharmacology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Medical Letter on Drugs and Therapeutics?

The Medical Letter on Drugs and Therapeutics is assigned the following International Standard Serial Numbers (ISSN): 0025732X, 15232859.


What's the best quartile of the Medical Letter on Drugs and Therapeutics?

The best quartile for the Medical Letter on Drugs and Therapeutics is Q3 (2022).


What's the coverage history of the Medical Letter on Drugs and Therapeutics?

The Medical Letter on Drugs and Therapeutics coverage history can be summarized as follows: 1965-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Proceedings of the ASME Turbo Expo conference and proceedings 17577 54 0.00
SPE Production and Operations Symposium, Proceedings conference and proceedings 15907 21 0.00
Journal of Geriatric Physical Therapy journal 5578 Lippincott Williams and Wilkins Ltd. 43 1.80
CESifo Economic Studies journal 14012 Oxford University Press 32 1.70
Mathematical Modelling and Analysis journal 11315 Vilnius Gediminas Technical University 27 1.75
Modern Language Journal journal 918 Wiley-Blackwell 103 3.89
Educational Measurement: Issues and Practice journal 4494 Wiley-Blackwell Publishing Ltd 59 1.53
Epigenetics journal 2362 Landes Bioscience 105 4.11
Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria journal 25905 National Association of Resident Doctors of Nigeria 25 0.00
East African journal of public health journal 19634 East African Public Health Association 23 0.00

Check complete list




Year wise Impact Score (IS) of Medical Letter on Drugs and Therapeutics

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 0.67
2021 0.67
2020 0.55
2019 0.53
2018 0.54
2017 0.43
2016 0.53
2015 0.71
2014 0.40



Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Drugs
Adis International Ltd | United Kingdom

Rheumatology
Oxford University Press | United Kingdom

Acta Pharmacologica Sinica
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Drug Resistance Updates
Churchill Livingstone | United States

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

See All